Publications by authors named "Harry Fuchssteiner"

Claim this Profile
I
Inflammatory Bowel Disease and Risk of Major Bleeding During Anticoagulation for Venous Thromboembolism.
Susanna Scharrer, Christian Primas, Sabine Eichinger, Sebastian Tonko, Maximilian Kutschera, Harry Fuchssteiner

Inflamm Bowel Dis· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of complementary and alternative medicine and low quality of life associate with the need for psychological and psychotherapeutic interventions in inflammatory bowel disease.
Maximilian Kutschera, Thomas Waldhör, Hans Peter Gröchenig, Thomas Haas, Heimo Wenzl, Harry Fuchssteiner

United European Gastroenterol J· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and indicators of use of complementary and alternative medicine in Austrian patients with inflammatory bowel disease.
Hans Peter Gröchenig, Thomas Waldhör, Thomas Haas, Heimo Wenzl, Pius Steiner, Harry Fuchssteiner

Eur J Gastroenterol Hepatol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic delay in patients with inflammatory bowel disease in Austria.
Gottfried Novacek, Hans Peter Gröchenig, Thomas Haas, Heimo Wenzl, Pius Steiner, Harry Fuchssteiner

Wien Klin Wochenschr· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Second Austrian consensus on the safe use of anti-TNFα-antibodies in patients with inflammatory bowel diseases].
Wolfgang Miehsler, Clemens Dejaco, Hans-Peter Gröchenig, Harry Fuchssteiner, Christoph Högenauer

Z Gastroenterol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical presentation of venous thromboembolism in inflammatory bowel disease.
Pavol Papay, Wolfgang Miehsler, Herbert Tilg, Wolfgang Petritsch, Walter Reinisch, Harry Fuchssteiner

J Crohns Colitis· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bleeding Dieulafoy lesions of the small bowel: a systematic study on the epidemiology and efficacy of enteroscopic treatment.
Emina Dulic-Lakovic, Melisa Dulic, Dietmar Hubner, Harry Fuchssteiner, Thomas Pachofszky

Gastrointest Endosc· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism.
Gottfried Novacek, Ansgar Weltermann, Anna Sobala, Herbert Tilg, Wolfgang Petritsch, Harry Fuchssteiner

Gastroenterology· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis